Nicorandil, a hybrid between nitrate and ATP-sensitive potassium channel opener, preconditions human heart to ischemia during percutaneous transluminal coronary angioplasty

Japanese Circulation Journal

Volumn 65, Issue 6, 2001, Pages 526-530

  Yasuda, T ^a   Hashimura, K ^a   Matsu Ura, Y ^a   Kato, Y ^a   Ueda, T ^a   Mori, I ^a   Kijima, Y ^a  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

ATP sensitive potassium channel; Ischemic preconditioning; Nicorandil; Percutaneous transluminal coronary angioplasty

Indexed keywords

ADENOSINE TRIPHOSPHATE; LACTIC ACID; NICORANDIL; NITRATE; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT;

ADULT; AGED; ANGINA PECTORIS; ARTERY LESION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HUMAN; LACTATE BLOOD LEVEL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LACTIC ACID; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NICORANDIL; PREMEDICATION; VASODILATOR AGENTS;

EID: 0035005147     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.65.526     Document Type: Article

References (40)

1. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
2. New insights into potential mechanisms of ischemic preconditioning
3. Protective effects of adenosine in myocardial ischemia
4. Alpha 1-adrenoceptor activation increases ecto-5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C
5. Alpha 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C
6. Sublethal ischemia alters myocardial antioxidant activity in canine heart
7. Cardiac stress protein elevation 24 h after brief ischemia or heat stress is associated with resistance to myocardial infarction
8. ATP-Sensitive potassium channels: A review of their cardioprotective pharmacology
9. Adenosine A 1 receptors, Katp channels, and ischemic preconditioning in dogs
10. Preconditioning the human myocardium
11. Previous angina alters in-hospital outcome in TIMI 4: A clinical correlate to preconditioning?
12. Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: Retrospective clinical evidence of 'preconditioning'
13. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: Clinical, hemodynamic, and metabolic features
14. + channel blocker
15. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium: Two paradoxes revisited
16. Nicorandil as a hybrid between nitrates and potassium channel activators
17. Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo
18. Effects of nicorandil and glyceryl trinítrate on infarct size, adenosine release, and neutrophil infiltration in the dog
19. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction
20. Disappearance of the 'no-reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction
21. Salutary effect of adjunctive intracoronary nicorandil administration on restoration of myocardial blood flow and functional improvement in patients with acute myocardial infarction
22. Antiischemic effects of nicorandil during coronary angioplasty in humans
23. Cardioprotection by opening of the Katp channel in unstable angina: Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil (CESAR 2 investigation: Clinical European studies in angina and revascularization)
24. Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction
25. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease
26. Effect of theophylline on adaptation of the heart to myocardial ischemia during percutaneous transluminal coronary angioplasty in patients with stable angina pectoris
27. Effects of intravenous nicorandil on coronary circulation in humans: Plasma concentration and action mechanism
28. Nicorandil affords cardioprotection in patients with acute myocardial infarction treated with primary percutaneous transluminal coronary angioplasty: Assessment with thallium-201/iodine-123 BMIPP dual SPECT
29. Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75)
30. + current by nicorandil (2-nicotinamidoethyl nitrate) in isolated ventricular myocytes
31. The effects of intracoronary adenosine on preconditioning during coronary angioplasty
32. Effects of A1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty
33. Preconditioning of human myocardium with adenosine during coronary angioplasty
34. + channels to A1 receptors by G proteins in rat ventricular myocytes
35. Adenosine primes the opening of mitochondrial ATP-sensitive potassium channels: A key step in ischemic preconditioning?
36. Mitochondrial Katp channels: Triggers or distal effectors of ischemic or pharmacological preconditioning?
37. Opening of mitochondrial Katp channels triggers the preconditioned state by generating free radicals
38. Role of mitochondrial and sarcolemmal Katp channels in ischemic preconditioning of the canine heart
39. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels
40. 5-HD abolishes ischemic preconditioning independently of monophasic action potential duration in the heart